• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1
1
1
1

COUNTRY

1

CATEGORIES

  • 8
  • 2
  • 1
  • 1
  • 1

PRICE

1
2
3
13

PUBLISHED

0
1
6
13

PRODUCT TYPE

11
2

Search "Bausch & Lomb Incorporated-Therapeutic Competitors Report" returned 13 results.

PRODUCT TITLE
Bausch & Lomb Incorporated Product Pipeline Analysis Bausch & Lomb Incorporated Product Pipeline Analysis - Product Thumbnail Image

Bausch & Lomb Incorporated Product Pipeline Analysis

Bausch & Lomb Incorporated Product Pipeline Analysis Summary This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The...

January 2009
FROM

Ocular Pain - Pipeline Review, H1 2014

Ocular Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ocular Pain - Pipeline Review, H1 2014’, provides an overview of the Ocular Pain’s therapeutic pipeline. This report provides...

May 2014
FROM

Open-Angle Glaucoma - Pipeline Review, H1 2015

Open-Angle Glaucoma - Pipeline Review, H1 2015 Summary This, ‘Open-Angle Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Open-Angle Glaucoma’s therapeutic pipeline. This report...

January 2015
FROM

Bacterial Conjunctivitis - Pipeline Review, H1 2014

Bacterial Conjunctivitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Bacterial Conjunctivitis - Pipeline Review, H1 2014’, provides an overview of the Bacterial Conjunctivitis’s therapeutic...

June 2014
FROM
France Medical Equipment Market Investment Opportunities, Analysis and Forecasts to 2012 France Medical Equipment Market Investment Opportunities, Analysis and Forecasts to 2012 - Product Thumbnail Image

France Medical Equipment Market Investment Opportunities, Analysis and Forecasts to 2012

France Medical Equipment Market Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for in-depth information and data relating to the French medical...

October 2008
FROM

Ocular Hypertension - Pipeline Review, H2 2014

Ocular Hypertension - Pipeline Review, H2 2014 Summary This, ‘Ocular Hypertension - Pipeline Review, H2 2014’, provides an overview of the Ocular Hypertension’s therapeutic pipeline. This report...

September 2014
FROM

Open-Angle Glaucoma - Pipeline Review, H2 2014

Open-Angle Glaucoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H2 2014’, provides an overview of the Open-Angle Glaucoma’s therapeutic pipeline. This...

July 2014
FROM

Open-Angle Glaucoma - Pipeline Review, H1 2014

Open-Angle Glaucoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H1 2014’, provides an overview of the Open-Angle Glaucoma’s therapeutic pipeline. This...

February 2014
FROM

Glaucoma - Pipeline Review, H1 2015

Glaucoma - Pipeline Review, H1 2015 Summary This, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Ocular Hypertension - Pipeline Review, H1 2014

Ocular Hypertension - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H1 2014’, provides an overview of the Ocular Hypertension’s therapeutic pipeline. This...

March 2014
FROM

Ocular Hypertension - Pipeline Review, H1 2015

Ocular Hypertension - Pipeline Review, H1 2015 Summary This, ‘Ocular Hypertension - Pipeline Review, H1 2015’, provides an overview of the Ocular Hypertension’s therapeutic pipeline. This report...

February 2015
FROM
Akorn, Inc (AKRX) - Financial and Strategic SWOT Analysis Review Akorn, Inc (AKRX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Akorn, Inc (AKRX) - Financial and Strategic SWOT Analysis Review

Akorn, Inc (AKRX) - Financial and Strategic SWOT Analysis Review Summary Akorn Inc. (Akorn) is a pharmaceutical company engaged in the development, manufacture and marketing of branded and multi source...

September 2011
FROM

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013 Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2013”...

August 2013
FROM
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.